EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The roles of mTORC1 in parathyroid gland function in chronic kidney disease‐induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data

Nareman Khalaily iD, Alia Hassan iD, Yasmeen Khream iD, Tally Naveh-Many iD, Iddo Z Ben-Dov iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202401547rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Nareman Khalaily und 4 weiteren Autor:innen. Beteiligte Einrichtung: Minerva Center for Bone and Mineral Research, Nephrology Services, Hadassah Hebrew University Medical Center and Faculty of Medicine, Jerusalem, Isra…. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Hyperparathyroidism, Secondary, Renal Insufficiency, Chronic, Parathyroid Glands. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation (ISF), United States - Israel Binational Science Foundation (BSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary hyperparathyroidism (SHP) associated with chronic kidney disease (CKD) contributes to morbidity and mortality, yet the related parathyroid signaling pathways are not fully understood. Previous studies have indicated that the parathyroid mTORC1 pathway is activated in both experimental CKD and hypocalcemia‐induced SHP. Furthermore, mice with parathyroid‐specific mTOR deficiency (PT‐ mTOR −/− ) exhibit disrupted parathyroid glands, but maintain normal serum PTH levels. Conversely, PT‐ Tsc1 −/− mice, with mTORC1 hyperactivation, have enlarged glands and high serum PTH and calcium levels. We now uncover links between mTORC1 function, parathyroid gland morphology, and the response to CKD. Despite impaired gland structure, PT‐ mTOR −/− mice increased serum PTH to levels similar to controls in response to CKD, but not to acute kidney injury (AKI), highlighting the adaptability of their parathyroid glands to chronic but not acute stimulation. PT‐ Tsc1 −/− mice, with enlarged glands also exhibited a CKD‐induced rise in serum PTH comparable to controls, but with a reduced magnitude, suggesting compromised secretion capacity. Parathyroid glands from PT‐ Tsc1 −/− mice displayed sustained high PTH secretion in culture, with no further increase when exposed to calcium‐depleted media, unlike control glands. Complementing these findings, human data from 106 healthcare organizations demonstrated that drug‐induced mTORC1 inhibition is associated with reduced serum PTH and a lower incidence of SHP in kidney transplant recipients. Collectively, our findings underscore the complex interplay between mTORC1 signaling and gland structure in the pathogenesis of SHP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Hyperparathyroidism, SecondaryRenal Insufficiency, ChronicParathyroid GlandsMice, KnockoutAnimalsMiceMaleHumansParathyroid HormoneDisease Models, AnimalTuberous Sclerosis Complex 1 ProteinTOR Serine-Threonine KinasesMice, Inbred C57BLCalciumFemaleSignal Transduction

Substanzen

Mechanistic Target of Rapamycin Complex 1Parathyroid HormoneTuberous Sclerosis Complex 1 ProteinTOR Serine-Threonine KinasesTsc1 protein, mouseCalcium

Autor:innen und Institutionen

  • Minerva Center for Bone and Mineral Research, Nephrology Services, Hadassah Hebrew University Medical Center and Faculty of Medicine, Jerusalem, Israel.
  • Wohl Institute for Translational Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Laboratory of Medical Transcriptomics, Nephrology and Internal Medicine B, Hadassah Hebrew University Medical Center and Faculty of Medicine, Jerusalem, Israel.

ORCID-Profile: Nareman Khalaily, Alia Hassan, Yasmeen Khream, Tally Naveh-Many, Iddo Z Ben-Dov

Förderung

  • Israel Science Foundation (ISF)
  • United States - Israel Binational Science Foundation (BSF)

Zitieren

APA

Khalaily, N., Hassan, A., Khream, Y., Naveh-Many, T., & Ben-Dov, I. Z. (2024). The roles of mTORC1 in parathyroid gland function in chronic kidney disease‐induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data. The FASEB Journal. https://doi.org/10.1096/fj.202401547rr

Vancouver

Khalaily N, Hassan A, Khream Y, Naveh-Many T, Ben-Dov IZ. The roles of mTORC1 in parathyroid gland function in chronic kidney disease‐induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data. The FASEB Journal. 2024. doi:10.1096/fj.202401547rr

BibTeX
@article{Khalaily2024,
  author = {Khalaily, Nareman and Hassan, Alia and Khream, Yasmeen and Naveh-Many, Tally and Ben-Dov, Iddo Z},
  title = {The roles of mTORC1 in parathyroid gland function in chronic kidney disease‐induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202401547rr}
}
Kostenlos starten →